Our model was built with disulfidptosis‐related risk scores which showed both accurate prediction of the prognosis of glioma patients and excellent distinction for several glioma molecular subtypes including grade, IDH mutation, MGMT promoter methylation, and 1p19q codeletion status. The gene discussed is MGMT; the disease is central nervous system cancer.